Phase II trial of Bisantrene for metastatic melanoma: an Illinois cancer council study
Sixteen patients with metastatic melanoma entered this phase II study of the efficacy of monthly cycles of Bisantrene. Toxicity was characterized by leukopenia, resulting in the hospitalization of one patient for a febrile incident, and superficial phlebitis. The results were similar to those of pre...
Saved in:
Published in | Medical and pediatric oncology Vol. 19; no. 2; p. 126 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
1991
|
Subjects | |
Online Access | Get more information |
Cover
Loading…
Summary: | Sixteen patients with metastatic melanoma entered this phase II study of the efficacy of monthly cycles of Bisantrene. Toxicity was characterized by leukopenia, resulting in the hospitalization of one patient for a febrile incident, and superficial phlebitis. The results were similar to those of previous studies, in that among the 13 patients evaluable for response (six previously untreated with chemotherapy) there were no responses. |
---|---|
ISSN: | 0098-1532 |
DOI: | 10.1002/mpo.2950190211 |